VivoSeq
Psychiatry

Substance Use

0

Pipeline Programs↗

7

Active Trials↗

0

Companies Involved↗

Substance Use is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

13/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

15

clinical trials

Completed6 · 40%
Recruiting4 · 27%
Terminated2 · 13%
Not yet recruiting2 · 13%
Active, not recruiting1 · 7%

Clinical Trials

Trial Activity

15 trials

STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Recruiting·MMedical University of South Carolina·N/A·NCT06922617·240 enrolled
Treating Polysubstance Use Using a Novel Digital Technology
Recruiting·FFriends Research Institute, Inc.·Phase 3·NCT05766631·240 enrolled
Role of Pavlovian Mechanisms for Control Over Substance Use
Recruiting·TTechnische Universität Dresden·N/A·NCT06701487·200 enrolled
The Cultural Adaptation of an Alcohol and Other Drug Use Treatment for Black Justice Involved Youth
Recruiting·UUniversity of California, San Francisco·Preclinical·NCT06003725·55 enrolled
Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure
Active, not recruiting·UUniversity of British Columbia·Phase 1·NCT05261321·20 enrolled
Testing and Evaluation of the Returning to the Land Intervention to Address and Prevent Substance Misuse
Not yet recruiting·JJohns Hopkins Bloomberg School of Public Health·Preclinical·NCT07695818·60 enrolled
Substance Use Prevention for Recently Displaced Adults - SUPRA (R33) RCT
Not yet recruiting·BBoston Medical Center·Preclinical·NCT07672457·144 enrolled
Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Patients With Active Illicit Substance usE
Completed·UUniversity of Nebraska·Phase 4·NCT03998176·43 enrolled
Guanfacine to Improve Substance Use Outcomes in Women
Completed·YYale University·Phase 2·NCT03980184·74 enrolled
Intermittent Naltrexone Among Polysubstance Users
Completed·UUniversity of California, San Francisco·Phase 2·NCT01723384·30 enrolled
Zepatier in Patients with Substance Use
Completed·UUniversity of Illinois at Chicago·N/A·NCT04048850·25 enrolled
Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use
Completed·—·Phase 4·NCT03842436·16 enrolled
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)
Completed·—·Phase 3·NCT03512418·30 enrolled
Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
Terminated·—·Phase 2·NCT00430573·15 enrolled
Intervention for Teens With ADHD and Substance Use
Terminated·FFlorida International University·Phase 3·NCT02502799·158 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)